Product Information
GLYBURIDE 1.25 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0689 per EA under NDC 75834020201. Its NADAC has been published 282 times since Oct 16, 2019.
Strength
1.25 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203379On Market Since
1/25/2019
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 1.25 MG TABLET has been published 282 times since Oct 16, 2019, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0689 per EA |
|---|---|
| All-time high | $0.1443 (Dec 11, 2019) |
| All-time low | $0.0561 (Jun 19, 2024) |
| Median price | $0.0848 |
| Average price | $0.0888 |
| Largest weekly change | +60.2% (Nov 22, 2023) |
| Weeks tracked | 282 |
| Tracking since | Oct 16, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLYBURIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 1.25 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0689 per EA (NDC 75834020201), effective Mar 5, 2025.
How has the price of GLYBURIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 1.25 MG TABLET has declined 39.3%. It has been tracked across 282 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 1.25 MG TABLET?
Since Oct 16, 2019, the NADAC for GLYBURIDE 1.25 MG TABLET has ranged from a low of $0.0561 (Jun 19, 2024) to a high of $0.1443 (Dec 11, 2019), with a median of $0.0848 per EA.
Are there cheaper alternatives to GLYBURIDE 1.25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as GLYBURIDE 1.25 MG TABLET, but none are currently priced below it.
Who manufactures GLYBURIDE 1.25 MG TABLET?
GLYBURIDE 1.25 MG TABLET (NDC 75834020201) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification